Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06708182 SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden |
SAGE LEAF 2: An Online Program to… | Alzheimer | Non applicable | COMPLETED | En attente / non publié | Northwestern University | United States · Northwestern University, Chicago, Uni… | 2025-07-02 → 2026-07-01 | Ouvrir |
| NCT07764679 A Clinical Study Evaluating the Diagnostic Performance and Safety of PE… |
[18F]Fluorbetazine injection | Alzheimer | Phase 3 | RECRUITING | En attente / non publié | HTA Co., Ltd. | China · Peking Union Medical College Hospital, Beijin… | 2025-06-20 → 2028-12-31 | Ouvrir |
| NCT00585572 WBDP — Wisconsin Brain Donor Program |
WBDP — Wisconsin Brain Donor Prog… | Alzheimer | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | University of Wisconsin, Madison | United States · University of Wisconsin Madison, Madi… | 2007-03 → 2050-08 | Ouvrir |
| NCT07284472 SERENADA — Safety and Efficacy of EXV-802 and EXV-801 in the Treatment … |
EXV-802 | Alzheimer | Phase 2/3 | RECRUITING | En attente / non publié | Exciva GmbH | United States, Canada, Czechia, Germany, Italy, Polan… | 2026-02-02 → 2029-02 | Ouvrir |
| NCT07033494 A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (M… |
MK-2214 | Alzheimer | Phase 2 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Canada,… | 2025-07-16 → 2029-04-30 | Ouvrir |
| NCT05617014 ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4 |
Neuraceq | Alzheimer | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | University of Southern California | United States, Canada · Albany Medical College, Alban… | 2023-06-09 → 2027-07-31 | Ouvrir |
| NCT05799690 Comparison of Different Rehabilitation Protocols in Parkinson's Disease… |
Comparison of Different Rehabilit… | Parkinson | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Prof. Massimo Filippi | Italy · IRCCS San Raffaele, Milan, Italy | Neurology … | 2023-04-30 → 2027-04-28 | Ouvrir |
| NCT00211224 Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIP… |
Riluzole | Parkinson | Phase 3 | TERMINATED | En attente / non publié | Corestemchemon, Inc. | United Kingdom · Institute of Psychiatry, King's Coll… | 2000-04 → 2004-11 | Ouvrir |
| NCT02230267 High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's D… |
High-intensity Exercise and Fall … | Parkinson | Phase 2 | COMPLETED | En attente / non publié | University of Nevada, Las Vegas | United States · University of Nevada, Las Vegas, Las … | 2014-08 → 2015-12 | Ouvrir |
| NCT05142085 Efficacy of Nano-PSO in Parkinson's Disease. |
Efficacy of Nano-PSO in Parkinson… | Parkinson | Non applicable | UNKNOWN | En attente / non publié | Distribuidora Biolife SA de CV | Mexico · Instituto Nacional de Neurologia y Neurociru… | 2021-09-20 → 2023-06-30 | Ouvrir |
| NCT05445505 Neuroprotective Effects of iTBS in PD |
Intermittent theta burst stimulat… | Parkinson | Non applicable | UNKNOWN | En attente / non publié | Ruijin Hospital | China · Department of neurology, Ruijin Hospital, Sha… | 2022-08-01 → 2024-12-31 | Ouvrir |
| NCT04305041 Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With … |
Pembrolizumab | Parkinson | Phase 1/2 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, France, Israel, Italy, Sout… | 2020-06-26 → 2025-08-25 | Ouvrir |
| NCT03076554 A Pilot Study to Investigate the Safety and Clinical Activity of Avelum… |
Avelumab | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2017-04-19 → 2028-03-30 | Ouvrir |
| NCT06312176 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in C… |
Sacituzumab Tirumotecan | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Brazil,… | 2024-04-14 → 2031-04-12 | Ouvrir |
| NCT07543861 FOGSTAND — A Pilot Study of In-lab Dynamic Standing in Parkinson's Dise… |
Dynamic Standing Desk | Parkinson | Phase 1 | RECRUITING | En attente / non publié | University of Michigan | United States · Domino's Farms, Ann Arbor, United Sta… | 2026-05-15 → 2027-03 | Ouvrir |
| NCT06573866 EQuAL — Enhancement of Quality of Work And Life |
EQuAL — Enhancement of Quality of… | Parkinson | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Radboud University Medical Center | Netherlands · Radboudumc, Nijmegen, Netherlands | 2024-10-08 → 2027-03-04 | Ouvrir |
| NCT05954013 PD_Pal — Advance Care Planning and Care Coordination for People With Pa… |
PD_Pal — Advance Care Planning an… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Radboud University Medical Center | Austria, Estonia, Germany, Greece, Italy, Sweden, Uni… | 2020-08-06 → 2023-03-17 | Ouvrir |
| NCT07764874 FREEDOM — Unilateral and Staged Bilateral Pallidothalamic Tractotomy Us… |
Unilateral Exablate MRgFUS Pallid… | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | InSightec | Korea University Anam Hospital, Seoul, South Korea | 2026-09 → 2031-06 | Ouvrir |
| NCT03268369 NICOPET — PET Study of the Nicotinic System in Epilepsy |
MRI of the brain | SEP | Non applicable | COMPLETED | En attente / non publié | Fabienne PICARD | Non communiqué | 2012-02 → 2015-11 | Ouvrir |
| NCT01491282 Study of the Effect of Vagus Nerve Stimulation on Human Brown Adipose T… |
Study of the Effect of Vagus Nerv… | SEP | À vérifier | UNKNOWN | En attente / non publié | Maastricht University | Netherlands · Maastricht University, Maastricht, Neth… | 2011-01 → 2012-11 | Ouvrir |
| NCT05785117 Vagal Nerve Stimulation as Therapeutic Approach on Metabolic Syndrome |
Vagal Stimulation | SEP | Non applicable | COMPLETED | En attente / non publié | Rana Elbanna | Egypt · Outpatient clinic faculty of physical therapy… | 2023-03-01 → 2023-05-30 | Ouvrir |
| NCT06938243 Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Po… |
Vagus Nerve Stimulation in early … | SEP | Phase 1 | RECRUITING | En attente / non publié | Qilu Hospital of Shandong Univers… | China · Qilu Hospital of Shandong University, Jinan, … | 2025-05-01 → 2026-12-30 | Ouvrir |
| NCT05289817 ESautonomous — Effects of Transcutaneous Electrical Stimulation on the … |
Transcutaneous Vagus Nerve Stimul… | SEP | Non applicable | COMPLETED | En attente / non publié | Universidade da Coruña | Spain · Universidade da Coruna, A Coruña, Spain | 2022-03-22 → 2022-06-29 | Ouvrir |
| NCT07132021 Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity … |
Active taVNS | SEP | Non applicable | RECRUITING | En attente / non publié | University of Liege | Brazil · Federal University of Pernambuco, Recife, Br… | 2025-08-01 → 2026-12-01 | Ouvrir |
| NCT07501611 Acute Cardiovascular Effects of Transcutaneous Auricular Vagus Nerve St… |
Active taVNS condition | SEP | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Northumbria University | United Kingdom · Northumbria University, Newcastle up… | 2026-03-01 → 2027-12-01 | Ouvrir |